Events

Neurotech2020: It’s a brave new world

It's an online conference, but not as you know it. Say goodbye to Zoom fatigue and hello to Neurotech2020. Understanding the brain, consciousness and thought...

Journalism Matters Week: We’re doing our bit!

2020 has been an incredible year. For journalists, and a huge number of other professions, it has been one of the biggest periods of...

Metabesity 2020 – extending healthspan virtually

Conference seeks to accelerate the translation of geroscience into material and equitable gains. Targeting Metabesity will be running 12-15 October 2020 with a packed virtual...

The revolution against aging will be televised

RAADfest 2020 kicks-off this week and will be digitally broadcast around the globe: we speak to its founder about the radical life extension movement. The...

What if there were an ‘Operation Warp Speed’ for aging?

Guest editorial and review of the Ending Age-Related Diseases (EARD) conference from Author of forthcoming book "Finding the Fountain" The destruction COVID-19 has caused not...

Next events being announced here

Building on the success of Longevity 2020, we have more events coming your way... Keep your diary handy! We have a host of not-to-be-missed conferences...

Latest articles

Epigenetic regulation of protein homeostasis following DNA damage

Recent study identifies critical regulator of protein biosynthesis recovery and homeostasis required for Longevity. Unresolved DNA damage caused by intrinsic and environmental factors accumulates during...

Deep Longevity and Longenesis collaborate to clock aging

Start the clock to stop the clock – centralised data will aid Longevity research.  Deep Longevity, which engages in the development of explainable AI systems...

Big Brother approach to accelerate preclinical studies

Tracked.bio develops AI computer vision system that tracks flies and mice to reduce man-hours and increase data collected in Longevity studies. A Danish start-up aims...

Astellas to acquire iota Biosciences

Following an R&D collaboration that began last year, Japanese pharma Astellas has announced it will acquire bioelectronics firm iota in $304m deal. Last year's R&D...